Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-003214-41Phase 4Completed
Phase 4, randomised trial in chronic kidney disease (CKD) comparing Furosemide + hydrochlorothiazide with Comparator/standard of care (2 arms). Primary endpoint: Interdialytic weight gain in long days at the end of each period. Started Sep 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-003214-41.